"[9EC880C4AFD0]" . . "I" . "15" . . . "5"^^ . "RIV/65269705:_____/13:#0002168" . "Diuretika v l\u00E9\u010Db\u011B hypertenze \u2013 doporu\u010Den\u00ED 2013"@cs . "Postgradu\u00E1ln\u00ED medic\u00EDna" . "Diuretika v l\u00E9\u010Db\u011B hypertenze \u2013 doporu\u010Den\u00ED 2013"@cs . "V roce 2013 vy\u0161la nov\u00E1 evropsk\u00E1 doporu\u010Den\u00ED pro diagnostiku a l\u00E9\u010Dbu hypertenze. V t\u011Bchto doporu\u010Den\u00EDch je potvrzena klasifikace hypertenze p\u0159ijat\u00E1 ji\u017E v roce 2003 (t\u0159i stupn\u011B hypertenze, t\u0159i stupn\u011B prehypertenze a izolovan\u00E1 systolick\u00E1 hypertenze) a je uvedeno p\u011Bt z\u00E1kladn\u00EDch skupin antihypertenz\u00EDv vhodn\u00FDch k zah\u00E1jen\u00ED l\u00E9\u010Dby i k udr\u017Eovac\u00ED terapii. Diuretika pat\u0159\u00ED mezi tyto z\u00E1kladn\u00ED l\u00E9kov\u00E9 skupiny. Jejich hlavn\u00ED indikac\u00ED u nemocn\u00FDch s hypertenz\u00ED je vy\u0161\u0161\u00ED v\u011Bk a izolovan\u00E1 systolick\u00E1 hypertenze, d\u00E1le dusnost a otoky. N\u011Bj\u010Dast\u011Bji p\u0159edepisovanou skupinou diuretik jsou thiazidy a jim podobn\u00E9 p\u0159\u00EDpravky, kter\u00E9 ale nejsou dob\u0159e tolerov\u00E1ny a maj\u00ED ne\u017E\u00E1douc\u00ED metabolick\u00E9 \u00FA\u010Dinky. Hlavn\u00ED m\u00EDsto diuretik je v kombina\u010Dn\u00ED l\u00E9\u010Db\u011B. Nej\u010Dast\u011Bji pou\u017E\u00EDvan\u00E9 diuretikum do kombinace je op\u011Bt hydrochlorothiazid a kombinuje se p\u0159edev\u0161\u00EDm s blok\u00E1tory renin angiotenzinov\u00E9ho syst\u00E9mu. Jako modern\u00ED a slibn\u00E1 kombinace se jev\u00ED ACE inhibitor + indapamid. Nevhodn\u00E1 kombinace je betablok\u00E1tor a diuretikum."@cs . "\u0160pinar, Jind\u0159ich" . "70017" . "Combination; Diuretics; hydrochlorothiazide; Diuretics; guidelines ESH/ASC"@en . "Diuretika v l\u00E9\u010Db\u011B hypertenze \u2013 doporu\u010Den\u00ED 2013" . . "RIV/65269705:_____/13:#0002168!RIV14-MZ0-65269705" . . "Diuretika v l\u00E9\u010Db\u011B hypertenze \u2013 doporu\u010Den\u00ED 2013" . "V roce 2013 vy\u0161la nov\u00E1 evropsk\u00E1 doporu\u010Den\u00ED pro diagnostiku a l\u00E9\u010Dbu hypertenze. V t\u011Bchto doporu\u010Den\u00EDch je potvrzena klasifikace hypertenze p\u0159ijat\u00E1 ji\u017E v roce 2003 (t\u0159i stupn\u011B hypertenze, t\u0159i stupn\u011B prehypertenze a izolovan\u00E1 systolick\u00E1 hypertenze) a je uvedeno p\u011Bt z\u00E1kladn\u00EDch skupin antihypertenz\u00EDv vhodn\u00FDch k zah\u00E1jen\u00ED l\u00E9\u010Dby i k udr\u017Eovac\u00ED terapii. Diuretika pat\u0159\u00ED mezi tyto z\u00E1kladn\u00ED l\u00E9kov\u00E9 skupiny. Jejich hlavn\u00ED indikac\u00ED u nemocn\u00FDch s hypertenz\u00ED je vy\u0161\u0161\u00ED v\u011Bk a izolovan\u00E1 systolick\u00E1 hypertenze, d\u00E1le dusnost a otoky. N\u011Bj\u010Dast\u011Bji p\u0159edepisovanou skupinou diuretik jsou thiazidy a jim podobn\u00E9 p\u0159\u00EDpravky, kter\u00E9 ale nejsou dob\u0159e tolerov\u00E1ny a maj\u00ED ne\u017E\u00E1douc\u00ED metabolick\u00E9 \u00FA\u010Dinky. Hlavn\u00ED m\u00EDsto diuretik je v kombina\u010Dn\u00ED l\u00E9\u010Db\u011B. Nej\u010Dast\u011Bji pou\u017E\u00EDvan\u00E9 diuretikum do kombinace je op\u011Bt hydrochlorothiazid a kombinuje se p\u0159edev\u0161\u00EDm s blok\u00E1tory renin angiotenzinov\u00E9ho syst\u00E9mu. Jako modern\u00ED a slibn\u00E1 kombinace se jev\u00ED ACE inhibitor + indapamid. Nevhodn\u00E1 kombinace je betablok\u00E1tor a diuretikum." . . "In 2013, new European recommendations for diagnosis and treatment of hypertension were issued. These recommendations confirmed the classification of hypertension already approved in 2003 (3 degrees of hypertension, 3 degrees of pre-hypertension and isolated systolic hypertension) and they list 5 basic groups of antihypertensives suitable for both initial and long term treatment. Diuretics belong among these groups. Their primary indication in patients with hypertension is higher age coupled with isolated systolic hypertension, along with shortness of breath and swellings. The most commonly prescribed group of diuretics are thiazides and similar preparations, which however tend to be poorly tolerated and they frequently have adverse metabolic effects. Diuretics are primarily used in a combined therapy. The most commonly used diuretic in combined treatment is hydrochrorothiazide, which is combined mostly with blockers of the renin-angio-tensin system. A modern and promising combination is an ACE inhibitor + indapamide. Combining beta-blockers with diuretics is inadvisable.."@en . . "CZ - \u010Cesk\u00E1 republika" . . . . . "9" . "Diuretics in hypertension treatment - 2013 recommendations"@en . "1212-4184" . . . "1"^^ . . "2"^^ . . "Diuretics in hypertension treatment - 2013 recommendations"@en . .